SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bandaram Pharma Pack - Quaterly Results

13 Aug 2024 Evaluate
The sales is pegged at Rs. 27.22 millions for the June 2024 quarter. The mentioned figure indicates a decline of about -33.56% as against Rs. 40.97 millions during the year-ago period.The Net Loss for the quarter ended June 2024 is Rs. -2.48 millions as compared to Net Profit of Rs. 0.55 millions of corresponding quarter ended June 2023Operating profit Margin for the quarter ended June 2024 slipped to -2.47% as compared to 0.59% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 27.22 40.97 -33.56 27.22 40.97 -33.56 148.39 100.94 47.01
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.27 0.00 0.00
PBIDT -2.47 0.59 -518.64 -2.47 0.59 -518.64 1.87 2.75 -32.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 -100.00
PBDT -2.47 0.59 -518.64 -2.47 0.59 -518.64 1.87 2.74 -31.75
Depreciation 0.01 0.04 -75.00 0.01 0.04 -75.00 0.15 0.02 650.00
PBT -2.48 0.55 -550.91 -2.48 0.55 -550.91 1.72 2.72 -36.76
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.43 0.68 -36.76
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -2.48 0.55 -550.91 -2.48 0.55 -550.91 1.29 2.04 -36.76
Equity 120.00 30.00 300.00 120.00 30.00 300.00 120.00 30.00 300.00
PBIDTM(%) -9.07 1.44 -730.11 -9.07 1.44 -730.11 1.26 2.72 -53.74

Bandaram Pharma Pack Share Price

28.14 -0.86 (-2.97%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×